Dr.S.Dhanvanthri Premvel'S Dhanvanthri Nilayam Ayurveda Vaidhyasalai Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 17-07-2024
- Paid Up Capital ₹ 0.50 M
as on 17-07-2024
- Company Age 7 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.02 M
as on 17-07-2024
- Revenue 17.13%
(FY 2023)
- Profit 113.29%
(FY 2023)
- Ebitda 95.35%
(FY 2023)
- Net Worth 55.91%
(FY 2023)
- Total Assets -4.45%
(FY 2023)
About Dr.S.Dhanvanthri Premvel'S Dhanvanthri Nilayam Ayurveda Vaidhyasalai
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹7.02 M.
Kavitha Premvel, Somasekar Premvel, and Prem Vishak serve as directors at the Company.
- CIN/LLPIN
U33309TN2017PTC116848
- Company No.
116848
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 May 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Madurai South, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Dr.S.Dhanvanthri Premvel'S Dhanvanthri Nilayam Ayurveda Vaidhyasalai?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kavitha Premvel  | Director | 30-May-2017 | Current |
| Somasekar Premvel | Director | 30-May-2017 | Current |
| Prem Vishak | Director | 30-May-2017 | Current |
Financial Performance of Dr.S.Dhanvanthri Premvel'S Dhanvanthri Nilayam Ayurveda Vaidhyasalai.
Dr.S.Dhanvanthri Premvel'S Dhanvanthri Nilayam Ayurveda Vaidhyasalai Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 17.13% increase. The company also saw a substantial improvement in profitability, with a 113.29% increase in profit. The company's net worth Soared by an impressive increase of 55.91%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dr.S.Dhanvanthri Premvel'S Dhanvanthri Nilayam Ayurveda Vaidhyasalai?
In 2023, Dr.S.Dhanvanthri Premvel'S Dhanvanthri Nilayam Ayurveda Vaidhyasalai had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Arushy Global Healthcare Technologies Private LimitedActive 1 year 8 monthsSomasekar Premvel and Prem Vishak are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 20 Jan 2024 | ₹7.02 M | Open |
How Many Employees Work at Dr.S.Dhanvanthri Premvel'S Dhanvanthri Nilayam Ayurveda Vaidhyasalai?
Unlock and access historical data on people associated with Dr.S.Dhanvanthri Premvel'S Dhanvanthri Nilayam Ayurveda Vaidhyasalai, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr.S.Dhanvanthri Premvel'S Dhanvanthri Nilayam Ayurveda Vaidhyasalai, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr.S.Dhanvanthri Premvel'S Dhanvanthri Nilayam Ayurveda Vaidhyasalai's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
